Skip to main content
Sister Publication Links
  • Middle East Foam & Polyurethane
  • UTECH Asia/PU China
  • UTECH Europe
  • UTECH Las Americas
Subscribe
  • My Account
  • Login
  • Subscribe
  • Ukraine
  • News
    • Asia
    • Americas
    • Europe
    • M & A
    • Financial results
    • Automotive
  • Data
  • Information
    • Country Overview
    • Market Sector overviews
    • Technical articles
    • Company profiles and strategies
  • Events
    • Exhibitions
    • Conferences
    • Webinars / Livestreams
    • Become a Speaker
  • Advertise
  • Contact Us
  • Issues
  • Subscribe
MENU
Breadcrumb
  1. Home
  2. News
November 27, 2008 12:00 AM

FDA approves PU catheters made by Avalon

Utech Staff
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    FDA approves PU catheters made by Avalon
    Surbiton, UK - US catheter maker Avalon Laboratories llc has received 10(k) approval from the US Food and Drug Administration (FDA) to market its  new Avalon Elite range, made with Elast-Eon, a biostable polyurethane elastomer with a high silicone content. Elast-Eon is a patented product of UK-headquartered medical polymer and device developer AorTech International plc. According to Aortech, this use will involve "substantive volumes of polymer sales for the company," in future.

    In a 25 Nov statement, AorTech said that Avalon's top of the range Elite catheters use "innovative engineering and broad proprietary manufacturing technologies," and can help in better care for patients suffering from debilitating diseases.

    FDA approval will allow full commercial launch of the catheters in the US. AorTech added that they have "performed extraordinarily well," in limited clinical trials in Europe earlier this year.

    Describing its relationship with Avalon as "an excellent fit for AorTech," Frank Maguire, AorTech ceo said, "Our ISO-certified manufacturing facility was designed specifically with this type of bulk polymer business in mind."

    For Avalon, ceo Robert Foster said, "The Elast-Eon material has some remarkable properties and it has found important applications in several implantable products. We have been extremely impressed with this innovative material and believe it will provide a tremendous benefit to the Avalon Elite."

    Another recent supply agreement announced in August for Elast-Eon was with an un-named company in the $300-million per year arterio-venous (AV) fistula market in the US. That deal included $250 000 in milestone payments, provisions for polymer sales and a single digit royalty, said AorTech,

    "The use of Elast-Eon in vascular connectors is a natural extension of the portfolio of uses in other blood-contacting products.  Elast-Eon's best in class biostability, processibility and blood-contacting performance make it an excellent choice for this application," said Maguire.

    As well as having similar biostability to silicone elastomers, AorTech says Elast-Eon has "excellent mechanical, blood contacting and flex-fatigue properties." It can also be processed as a thermoplastic by extrusion or moulding.

    "

    Recommended for You
    UTECH Awards 2024 nominations open
    UTECH Europe 2024 – Polyurethane Awards open for entries
    corn maize 800
    BASF deal with Qore secures supply of raw material for biobased TPU
    Novel XDI-based crosslinker creates flexible adhesives with good recovery
    Novel XDI-based crosslinker creates flexible adhesives with good recovery
    Latest Issue
    urethanes technology
    Get the latest edition here
    View All Archives
    Get our newsletters

    Breaking news and in-depth coverage of essential topics delivered straight to your inbox.

    Subscribe today

    Register to access our archive of leading information on the polyurethanes industry.

    Subscribe now
    Connect with Us
    • Twitter
    • LinkedIn
    • Facebook
    • Youtube

    Follow us on social media for the latest polyurethanes industry news and event updates.

    Logo
    Contact Us

    Crain Communications
    11, Ironmonger Lane
    London
    EC2V 8EY
    United Kingdom

    Editorial
    Phone +44 (0) 20 3287 5935
    Email click to send

    Customer Service
    Phone +1 313 446 0450
    Email click to send

    Resources
    • Advertise with Us
    • Media Kit
    • Staff
    • Careers
    • Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Ukraine
    • News
      • Asia
      • Americas
      • Europe
      • M & A
      • Financial results
      • Automotive
    • Data
    • Information
      • Country Overview
      • Market Sector overviews
      • Technical articles
      • Company profiles and strategies
    • Events
      • Exhibitions
      • Conferences
      • Webinars / Livestreams
      • Become a Speaker
    • Advertise
    • Contact Us
    • Issues
    • Subscribe